AAAAAA

   
Results: 1-4 |
Results: 4
The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells
Authors: Cartee, L Wang, ZL Decker, RH Chellappan, SP Fusaro, G Hirsch, KG Sankala, HM Dent, P Grant, S
Citation: L. Cartee et al., The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells, CANCER RES, 61(6), 2001, pp. 2583-2591
Rb dephosphorylation and suppression of E2F activity in human breast tumorcells exposed to a pharmacological concentration of estradiol
Authors: Gewirtz, DA Di, YM Randolph, JK Jain, PT Valerie, K Bullock, S Nath, N Chellappan, SP
Citation: Da. Gewirtz et al., Rb dephosphorylation and suppression of E2F activity in human breast tumorcells exposed to a pharmacological concentration of estradiol, ARCH BIOCH, 388(2), 2001, pp. 243-252
Viral oncoproteins as probes for tumor suppressor function
Authors: Chellappan, SP
Citation: Sp. Chellappan, Viral oncoproteins as probes for tumor suppressor function, CANC DRUG, 2000, pp. 29-48
HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity
Authors: Nath, N Bian, H Reed, EF Chellappan, SP
Citation: N. Nath et al., HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity, J IMMUNOL, 162(9), 1999, pp. 5351-5358
Risultati: 1-4 |